Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

著者: Samuel Lederman, Faith D Ottery, Antonio Cano, Nanette Santoro, Marla Shapiro, Petra Stute, Rebecca C. Thurston, Marci English, Catherine Franklin, Misun Lee, Genevieve Neal-Perry - The Lancet 2023 被引用: 244